FDA establishment 3022351866, Waltham, Massachusetts, United States. Part of Thea Pharma's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations and its recalls since 2016.
FY2018 to FY2027 to date; 0 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
| Oct 18, 2024 | Drugs · Bioresearch Monitoring | None posted | No Action Indicated (NAI) |
| Jun 6, 2024 | Biologics · Human Cellular, Tissue, and Gene Therapies | None posted | No Action Indicated (NAI) |
| iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in France, Distributed by…Drug · D-0500-2026 · 2 products | Class II | Apr 23, 2026 |
| Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc.…Drug · D-0374-2024 | Class II | Mar 5, 2024 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections. FDA Data Dashboard, warning letters and enforcement reports